Patients Physician Practices Manufacturers Payers
US Oncology Return to US Oncology Homepage
AUDIENCE TAB
       
   
Clinical Trials Details

Pancreatic Cancer

A Phase 2 Double-Blind, Placebo Controlled, Multi-center Adjuvant Trial of the Efficacy, Immunogenicity, and Safety of GI-4000; an Inactivated Recombinant Saccharomyces cerevisiae Expressing Mutant Ras Protein Combined with a Gemcitabine Regimen Vers

Trial ID: 05089

Contact: Lisa Sherman

Phone: (281)863-6658

Learn More about this trial.


go back | new search

This Study is currently being offered at the following Sites:
PracticeState/City
Minnesota Oncology Hematology, P.A.Burnsville, MN
Texas Oncology, P.A.Dallas, TX (Methodist)
Texas Oncology, P.A.Dallas, TX (Presbyterian)
Minnesota Oncology Hematology, P.A.Edina, MN
Minnesota Oncology Hematology, P.A.Maplewood, MN
Minnesota Oncology Hematology, P.A.Minneapolis, MN
Cancer Centers of Florida, P.A.Orlando, FL (Lake Underhill)
Minnesota Oncology Hematology, P.A.St. Paul, MN
Texas Oncology, P.A.Tyler, TX
Minnesota Oncology Hematology, P.A.Woodbury, MN

Text Size Print
 
Network Map
Search Clinical Trials
Frequently Asked Questions for Patients
URL Format  Why do physicians choose US Oncology network practices?
URL Format  Why is Research so important?
 
     
Copyright
[FindPracticePhysician] [GetAdobeReader] [Home] [Help] [SiteMap] [TermsofUse] [ForEmployees] RightSlice RightSlice